Innovent Biologics Initiates Phase III Trial for Mazdutide in OSA and Obesity
CompanyDrug

Innovent Biologics Initiates Phase III Trial for Mazdutide in OSA and Obesity

Abbisko Therapeutics Launches Clinical Study of FGFR4 Inhibitor in Advanced Hepatocellular Carcinoma
CompanyDrug

Abbisko Therapeutics Launches Clinical Study of FGFR4 Inhibitor in Advanced Hepatocellular Carcinoma

Dessight Biomedical Secures RMB 100M Series A Funding for Surgical Robot Development
CompanyDeals

Dessight Biomedical Secures RMB 100M Series A Funding for Surgical Robot Development

AstraZeneca Launches Truqap in China for PIK3CA/AKT1/PTEN-Altered Breast Cancer
CompanyDrug

AstraZeneca Launches Truqap in China for PIK3CA/AKT1/PTEN-Altered Breast Cancer

CR Sanjiu Partners with HELP Therapeutics to Advance iPSC-based Heart Failure Therapy
CompanyDeals

CR Sanjiu Partners with HELP Therapeutics to Advance iPSC-based Heart Failure Therapy

Raffles Medical Partners with CQMU First Hospital to Enhance Healthcare Services
CompanyDeals

Raffles Medical Partners with CQMU First Hospital to Enhance Healthcare Services

AstraZeneca and CSPC Pharma Collaborate on Novel Oral Drug Discovery
CompanyDeals

AstraZeneca and CSPC Pharma Collaborate on Novel Oral Drug Discovery

CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments
CompanyDeals

CF PharmTech Files for Hong Kong IPO to Expand Respiratory Disease Treatments

Cloudbreak Pharma Files for Hong Kong IPO Amid Ophthalmic Drug Development
CompanyDeals

Cloudbreak Pharma Files for Hong Kong IPO Amid Ophthalmic Drug Development

Nona Biosciences Licenses HCAb Technology to Visterra for Biologic Development
CompanyDeals

Nona Biosciences Licenses HCAb Technology to Visterra for Biologic Development

BioNTech in Deal to Acquire CureVac for $1.25B to Boost Cancer mRNA Therapies
CompanyDeals

BioNTech in Deal to Acquire CureVac for $1.25B to Boost Cancer mRNA Therapies

AbbVie's Mavyret Gains FDA Approval for Acute HCV in Children and Adults
CompanyDrug

AbbVie’s Mavyret Gains FDA Approval for Acute HCV in Children and Adults